Parenteral Systems Target Dosing Ease and Needle Safety.

Ypsomed AG (Burgdorf, Switzerland) has focused on the development of pens and autoinjection systems for pre-filled syringes for delivery of insulin, GLP-1s, hormones, and autoimmune disease treatments. Two new cartridge-based pens for insulin are in development, the UnoPen, a disposable one-time-use system, and the ServoPen. A reusable device, the SevoPen is a spring–driven automatic, dial-and-dose pen, with a large display, says Ian Thompson, head of business development.

Ypsomed is planning a 2010 launch of the ClickFine Auto Protect Safety Pen Needle for use mainly for insulin injections performed in clinical settings, Thompson says.
For needle safety, a needle shield is activated when the needle is inserted into the skin and locks out when the needle is removed. A red bolt clearly signals that the needle has been used, he adds.
“All of our new platforms including the monodose dual-chamber pen and syringe-based auto-injector systems are designed with the patient in mind. We have focused on providing devices with the necessary patient-oriented feature set but that still allow the patient control over the injection process.”
No votes yet

The safety is needed here so

The safety is needed here so much. I hope to see so much great work coming from this. I hope to see better work on this in the future. Safety is so important. paxil class action lawsuit

android smart phones

It is really a great and helpful piece of information. I'm glad that you shared this helpful information with us. Please keep us up to date like this. Thank you for sharing.
android smart phones

Fantastic blog! I don’t

Fantastic blog! I don’t think I’ve seen all the angles of this subject the way you’ve pointed them out. You’re a true star, a rock star man. You’ve got so much to say and know so much about the subject that I think you should just teach a class about it
Cell phone spying